Related by context. Frequent words. (Click for all words.) 80 Advanced Prostate Cancer 80 Elderly Patients 80 Patients Undergoing 78 Prostate Cancer Patients 75 Heart Failure Patients 75 Cardiovascular Events 75 Metastatic Colorectal Cancer 75 Postmenopausal Women 74 Lung Cancer Patients 74 Overactive Bladder 74 Well Tolerated 74 Diabetic Patients 73 Patients Treated 73 Breast Cancer Treatment 73 Breast Cancer Patients 73 Monotherapy 72 Metastatic Melanoma 71 Hormone Therapy 71 Prostate Cancer Treatment 71 Venous Thromboembolism 71 Newly Diagnosed 71 Gum Disease 71 Chronic Hepatitis C 71 Bevacizumab 70 Survival Rates 70 Phase III Clinical Trial 70 Drug Candidate 70 Cancer Treatments 70 Gastric Cancer 70 Blood Clots 70 Benign Prostatic Hyperplasia 70 Meta Analysis 70 Urinary Tract Infections 70 Phase III Trial 70 Increases Risk 70 Low Dose 70 Reduces Risk 69 Tolerability 69 Combination Therapy 69 Blood Vessels 69 Randomized Controlled Trial 69 Malignancies 69 Clinical Trial Results 69 Urinary Incontinence 68 Irinotecan 68 Bypass Surgery 68 II Clinical Trial 68 Increased Risk 68 Cognitive Decline 68 Dialysis Patients 68 Capecitabine 68 Ischemic 68 Trastuzumab 68 Patient Enrollment 68 Drug Resistant 68 Carcinoma 68 Regimens 68 Pivotal Trial 67 Metastatic 67 Stem Cell Transplant 67 Resection 67 Bone Density 67 Bladder Cancer 67 Blood Vessel 67 Patient Outcomes 67 C Reactive Protein 67 FDA Clears 67 Chronic Heart Failure 67 Kidney Stones 67 Pulmonary Arterial Hypertension 67 Cancer Diagnosis 67 Solid Tumors 67 Preclinical Data 67 Radiation Exposure 67 Insulin Resistance 67 Gemcitabine 67 Allergic Rhinitis 67 FDA Clearance 66 Acute Coronary Syndromes 66 Significantly Reduces 66 Completes Enrollment 66 Relapsed 66 Pivotal Phase 66 Recombinant Human 66 Study Demonstrates 66 Breast Cancer Risk 66 Mastectomy 66 Stenting 66 Asymptomatic 66 Prophylaxis 66 Chronic Lymphocytic Leukemia 65 Inhibits 65 Ear Infections 65 Blood Thinner 65 Anti TNF 65 Blood Flow 65 Esophageal Cancer 65 Prostate Cancer Risk 65 Antipsychotic 65 Pivotal Phase III 65 Atopic Dermatitis